Recursion Pharmaceuticals... (RXRX)
NASDAQ: RXRX
· Real-Time Price · USD
5.51
-0.26 (-4.51%)
At close: Aug 18, 2025, 3:59 PM
5.56
0.82%
After-hours: Aug 18, 2025, 07:59 PM EDT
Recursion Pharmaceuticals Revenue
Recursion Pharmaceuticals reported an annual revenue of $58.84M, reflecting a 32% growth. For the quarter ending June 30, 2025, Recursion Pharmaceuticals generated $19.1M in revenue.
Revenue (ttm)
58.84M
Revenue Growth
32%
Price / Sales Ratio
31.5
Revenue / Employee
73.55K
Employees
800
Market Cap
2.36B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 58.84M | +32.00% |
Dec 31, 2023 | 44.58M | +12.33% |
Dec 31, 2022 | 39.68M | +296.81% |
Dec 31, 2021 | 10M | +193.00% |
Dec 31, 2020 | 3.41M | +99.47% |
Dec 31, 2019 | 1.71M | n/a |